SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-025507
Filing Date
2020-12-17
Accepted
2020-12-17 07:29:19
Documents
16
Period of Report
2020-12-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20201216_8k.htm   iXBRL 8-K 27133
2 EXHIBIT 99.1 ex_217919.htm EX-99.1 13469
7 ex_217919img001.jpg GRAPHIC 4564
8 mbrx20201216_8kimg001.jpg GRAPHIC 3620
  Complete submission text file 0001437749-20-025507.txt   199137

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20201217.xsd EX-101.SCH 3701
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20201217_def.xml EX-101.DEF 11973
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20201217_lab.xml EX-101.LAB 16011
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20201217_pre.xml EX-101.PRE 12182
9 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20201216_8k_htm.xml XML 2656
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 201394232
SIC: 2834 Pharmaceutical Preparations